References
- Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurology50(3), 389–400 (2001).
- Vercellino M, Masera S, Lorenzatti M et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J. Neuropathol. Exp. Neurol.68(5), 489–502 (2009).
- Kutzelnigg A, Lucchinetti CF, Stadelmann C et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain128(11), 2705–2712 (2005).
- Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain122(1), 17–26 (2001).
- Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol.7(9), 841–851 (2008).
- Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology236(1), 254–260 (2005).
- Sailer M, Fischi B, Salat D et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain126(8), 1734–1744 (2003).
- Dalton CM, Chard DT, Davies GR et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain127(5), 1101–1107 (2004).
- Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, Miller DH, Thompson AJ. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage22(1), 353–359 (2004).
- Ramasamy DP, Benedict R, Cox J et al. Extent of cerebellum, subcortical and cortical atrophy in patients with MS. A case–control study. J. Neurol. Sci.282, 47–54 (2009).
- Calabrese M, Gallo P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult. Scler.15(8), 933–941 (2009).
- Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti CF. A case of multiple sclerosis presenting with inflammatory cortical demyelination. Neurology76(20), 1705–1710 (2011).
- Barkhof F. The clinico–radiological paradox in multiple sclerosis revisited. Curr. Opin. Neurol.15(3), 239–245 (2002).
- Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, ThompsonAJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N. Eng. J. Med.346(3), 158–164 (2002).
- Fisniku LK, Chard DT, Jackson JS et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann. Neurol.64(3), 247–254 (2008).
- Roosendaal SD, Bendfeldt K, Vrenken H et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult. Scler.17(9), 1098–1106 (2011).
- Jasperse B, Valsasina P, Neacsu V et al. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually edited SIENA and SIENAX. J. Magn. Reson. Imaging26(4), 881–885 (2007).
- De Stefano N, Matthews PM, Filippi M et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology60(7), 1157–1162 (2003).
- Calabrese M, Rocca MA, Atzori M et al. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann. Neurol.67(3), 376–383 (2010).
- Roosendaal SD, Moraal B, Pouwels PJ et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult. Scler.15(6), 708–714 (2009).
- Calabrese M, Agosta F, Rinaldi F et al. Cortical lesions and atrophy associated with cognitive impairment in relapsingremitting multiple sclerosis. Arch. Neurol.66(9), 1144–1150 (2009).
- Rovaris M, Judica E, Gallo A et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain129(10), 2628–2634 (2006).
- Amato MP, Portaccio E, Goretti B et al. Cognitive impairment in early stages of multiple sclerosis. Neurol. Sci.31, S211–S214 (2010).
- Calabrese M, Rinaldi F, Mattisi I et al. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology74(4), 321–328 (2010)
- Filippi M, Rocca MA, Calabrese M et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology75(22), 1988–1994 (2010).
- Calabrese M, Rinaldi F, Mattisi I et al. The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology77(3), 257–263 (2011).
- Polman CH, Reingold SC, Banwell B et al. Diagnostic criteria for multiple sclerosis: 2010 revision to the McDonald criteria. Ann. Neurol.69(2), 292–302 (2011).
- Filippi M, Rovaris M, Inglese M et al Interferon β-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet364(9444), 1489–1496 (2004).
- Calabrese M, Bernardi V, Atzori M et al. Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple. Mult. Scler. DOI: 10.1177/1352458510394702 (2011) (Epub ahead of print).
- Bendfeldt K, Egger H, Nichols TE et al. Effect of immunomodulatory medication on regional gray matter loss in relapsing–remitting multiple sclerosis – a longitudinal MRI study. Brain Res.14(1325), 174–182 (2010).
- Derfuss T, Parikh K, Velhin S et al. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc. Natl Acad. Sci. USA19(106), 8302–8307 (2009).